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Toll-like receptors (TLRs) play a central role in macrophage activation and control of parasitic infections.
Their contribution to the outcome of Leishmania infection is just beginning to be deciphered. We examined the
interaction of Leishmania panamensis with TLRs in the activation of host macrophages. L. panamensis infection
resulted in upregulation of TLR1, TLR2, TLR3, and TLR4 expression and induced tumor necrosis factor alpha
(TNF-) secretion by human primary macrophages at comparable levels and kinetics to those of specific TLR
ligands. The TLR dependence of the host cell response was substantiated by the absence of TNF- production
in MyD88/TRIF/ murine bone marrow-derived macrophages and mouse macrophage cell lines in response
to promastigotes and amastigotes. Systematic screening of TLR-deficient macrophages revealed that TNF-
production was completely abrogated in TLR4/ macrophages, consistent with the increased intracellular
parasite survival at early time points of infection. TNF- secretion was significantly reduced in macrophages
lacking endosomal TLRs but was unaltered by a lack of TLR2 or MD-2. Together, these findings support the
participation of TLR4 and endosomal TLRs in the activation of host macrophages by L. panamensis and in the
early control of infection.
Protozoan parasites of the genus Leishmania are obligate
intracellular pathogens that infect and impact the lives of mil-
lions of people worldwide. Leishmania species induce a broad
spectrum of pathologies in humans, ranging from cutaneous
lesions to progressive fatal visceral disease (43). Although the
determinants of pathogenesis remain unclear, the host im-
mune response and the infecting Leishmania species contrib-
ute to the diverse clinical manifestations (57).
Macrophages act as the principal host cells for Leishmania,
playing a central role in the development of the immune re-
sponse to these parasites via antigen presentation, secretion of
microbicidal products, and production of inflammatory medi-
ators (cytokines and chemokines). These early events during
host cell-parasite interaction can ultimately determine the out-
come of infection (9). Previous studies of naturally infected
humans have provided evidence of differences in the innate
and acquired immune responses to Leishmania (Viannia) sub-
species associated with the clinical outcome of infection. Mac-
rophages from naturally exposed individuals presenting recur-
rent or chronic disease (clinical susceptibility) were more
permissive to in vitro infection than cells from individuals with
subclinical infection (clinical resistance) (9, 52).
Experimental studies have revealed that a diverse repertoire
of receptors is involved in Leishmania-macrophage interac-
tions (5, 11, 37, 39); nevertheless, the relationships between
these receptors, host cell activation, and outcome of infection
remain largely unknown. Toll-like receptors (TLRs) provide a
link between innate and adaptive immunity, allowing recogni-
tion of a wide range of microbial products, including those of
protozoan pathogens (22, 24, 35). TLR-ligand interaction ini-
tiates signal transduction through the adaptor proteins MyD88
and/or TRIF, resulting in downstream activation of NF-B and
interferon (IFN) regulatory factors and the subsequent tran-
scription of inflammatory mediators such as tumor necrosis
factor alpha (TNF-), type I interferons, and interleukin-12
(IL-12) and of the costimulatory molecules CD80 and CD86 in
monocytes/macrophages and dendritic cells (DCs).
Gene knockout studies with mice have revealed a critical
role for TLR signaling in the immune response against Leish-
mania parasites (32, 60). MyD88/ and TLR4/ C57BL/6
mice were more susceptible to disease following Leishmania
major infection (17, 19, 30, 31, 42), and depletion of TLR9
impaired NK cell activation in murine models of both visceral
leishmaniasis caused by L. infantum and cutaneous leishman-
iasis produced by L. major (33, 55). A link between TLRs and
microbicidal capacity was evidenced by the requirement of
TLR2 and TLR3 for intracellular killing of L. donovani organ-
isms in IFN--primed macrophages (21). Notably, the absence
of TLR2 was recently shown to promote IL-12 production by
DCs during L. braziliensis infection, suggesting that this recep-
tor may also play a negative regulatory role (61).
Although knowledge of the nature and identity of Leish-
mania molecules that interact with individual TLRs is limited,
some parasite ligands and cognate TLR receptors on different
cells participating in the immune response have been de-
scribed. L. major lipophosphoglycan (LPG) was shown to ac-
tivate human NK cells and murine monocytes through TLR2
(3, 19) and has been implicated in the induction of nitric oxide
(NO) production by human peripheral blood mononuclear
cells (PBMCs) via TLR2 (27). Additionally, the P8 proteoglyco-
lipid complex (P8 PGLC) expressed by L. pifanoi was recently
shown to promote macrophage activation through TLR4 (62),
and L. major DNA was shown to activate DCs through TLR9
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and thereby to promote IFN- production by CD4 T cells (1).
The implications of these findings and the participation of
TLR signaling in the onset of the immune response during
human infections with species of the Leishmania (Viannia)
subgenus have yet to be determined.
Th1/Th2 polarization does not explain the clinical outcome
of human infections with Leishmania (Viannia) species, which
have a propensity to produce latent infection and relapsing (2)
and chronic disease. Early in vitro responses are characterized
by a mixed profile of proinflammatory (IFN- and TNF-) and
anti-inflammatory (IL-10 and IL-13) cytokine production (20).
Refractory disease presentations are often accompanied by
exuberant Th1 responses, including increased TNF- produc-
tion, which has been implicated in pathogenesis (54). In this
study, we present evidence that TLRs are involved in both
activation and secretion of TNF- by human and murine mac-
rophages infected by L. panamensis and participate in the early
control of infection.
MATERIALS AND METHODS
Parasites. L. panamensis (MHOM/CO/86/1166) promastigotes were cultured
in Schneider’s Drosophila medium (Sigma) supplemented with 20% heat-inac-
tivated fetal bovine serum (HIFBS) (Gibco) at 25°C. Luciferase- and green
fluorescent protein (GFP)-expressing promastigotes (L.p-Luc and L.p-GFP)
were grown in medium supplemented with 50 mg/ml of G418 (Gibco). Promas-
tigotes were harvested during stationary phase and opsonized for 1 h at 34°C in
RPMI 1640 (Gibco) supplemented with 10% heat-inactivated human AB serum
when indicated. Live intracellular amastigotes were obtained by infection of
differentiated adherent U937 cells with opsonized promastigotes (50:1 parasite-
to-cell ratio) for 5 days at 34°C and 5% CO2. After infection, cells were lysed by
passage through a 27G needle, and amastigotes were recovered by centrifugation
over a Percoll density gradient (Amersham Biosciences).
Macrophages. Human promonocytic U-937 cells were cultured as previously
described (52). Cell differentiation was induced by phorbol 12-myristate 13-
acetate (PMA) stimulation (100 ng/ml) (Sigma) 4 days prior to infection. Im-
mortalized macrophage cell lines generated from wild-type (WT), MyD88/
TRIF/, MyD88/, TRIF/, TLR2/, TLR4/, and UNC93b mutant
C57BL/6 mice were cultured as previously described (23). Clonal lines were
tested for the induction of TNF- and IL-6 in response to a panel of TLR
ligands, including synthetic lipopeptide, polyinosinic-poly(C) [poly(I:C)], lipo-
polysaccharide (LPS), resiquimod, and CpG DNA. In all cases, the predicted
responses, based on the known responses of native bone marrow-derived mac-
rophages (BMMs), were observed (e.g., the TLR4 knockout responded to all
TLR ligands except for LPS). Cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Cellgro) supplemented with 10% HIFBS and 10 g
of ciprofloxacin/ml (Bayer). Cells were plated and stimulated with TLR ligands
or infected with L. panamensis parasites as described in the text.
All mice were housed and bred under pathogen-free conditions. Bone marrow
was harvested from mice as previously described (62), in accordance with the
guidelines set forth by the University of Massachusetts Medical School and
approved by its Institutional Animal Care and Use Committee. BMM precursors
from WT (C57BL/6), MD-2/, MyD88/TRIF/, MyD88/, TRIF/, or
TLR4/ mice were differentiated in culture for 9 to 10 days in the presence of
conditioned medium (DMEM supplemented with 20% L929 cell culture super-
natant, 10% HIFBS, and 10 g/ml ciprofloxacin) prior to use.
Isolation and culture of human monocyte-derived macrophages. Sixty millili-
ters of peripheral blood was obtained from healthy adult volunteers in accor-
dance with the protocol and with informed consent forms approved by the
Institutional Review Board of the Centro Internacional de Entrenamiento e
Investigaciones Medicas (CIDEIM). PBMCs were obtained from peripheral
blood by Ficoll-Hypaque 1077 (Sigma) density gradient centrifugation. Mono-
cytes were allowed to differentiate into macrophages by culture for 7 days at 37°C
and 5% CO2 in complete RPMI (Sigma) following adherence to plates coated
with 2% sterile endotoxin-free gelatin and autologous human serum. All plas-
ticware, glassware, and water used for cell culture were endotoxin free.
L. panamensis infection and TLR ligand stimulation. Primary human macro-
phages were stimulated for 8 h with LPS (1 g/ml), zymosan (25 g/ml),
Pam2CSK4 (10 g/ml), poly(I:C) (20 g/ml), or CpG ODN 2216 (5 M) (Invi-
vogen) or infected with opsonized L. panamensis promastigotes at a 5:1 parasite-
to-cell ratio. Infection was allowed to proceed for 1 h in FBS-free medium at
34°C and 5% CO2. Extracellular parasites were removed by washing with Dul-
becco’s phosphate-buffered saline (DPBS), and cells were incubated for 8 h at
34°C and 5% CO2.
Mouse macrophage cell lines and BMMs were infected with L. panamensis
promastigotes and amastigotes at 50:1 to 200:1 parasite-to-cell ratios for 1 h,
washed with DPBS, and incubated at 34°C and 5% CO2. These parasite-to-cell
ratios, using serum-opsonized as well as nonopsonized parasites, were chosen to
optimize infection and readout based on prior dose-response experiments. Su-
pernatants were collected and TNF- was evaluated at 24 h postinfection. Stim-
ulations with Pam2CSK4 (4 M), poly(I:C) (100 g/ml), CpG (5 M), and LPS
(1 g/ml) or with the non-TLR ligand Sendai virus (500 U/ml) were used as
positive and negative controls, as indicated. The TLR4/MD-2 antagonist Erito-
ran (10 g/ml) (Eisai Research Institute) was used to discriminate activation
attributable to endotoxin contamination. Infection was evaluated in Giemsa-
stained cells by microscopy.
WT and TLR4/ macrophages were seeded on glass coverslips and infected
with L.p-GFP promastigotes at a 20:1 parasite-to-cell ratio to visualize parasite
internalization by confocal microscopy (Leica SP2 AOBS confocal microscope).
Cell membranes were stained with CellMask Deep Red stain (Invitrogen).
Fluorescence-activated cell sorter (FACS) analysis. Human macrophages
were harvested, incubated with 10 g of nonimmune human IgG (BD Biosci-
ences) to block nonspecific binding to FcR, and then incubated with phyco-
erythrin (PE)-labeled monoclonal anti-TLR1 (clone GD2.F4), anti-TLR2 (clone
TL2.1), or anti-TLR4 (clone HTA125) antibody. Fluorescein isothiocyanate
(FITC)-labeled anti-CD14 was used as a monocyte population marker. For
intracellular staining, cells were fixed and permeabilized with Cytofix/Cytoperm
solution, washed with PermWash solution (BD Biosciences), and incubated with
monoclonal anti-TLR3 (clone TLR3.7) or anti-TLR9 (eB72-1665). Cells were
fixed with 2% paraformaldehyde. PE-IgG1, PE-mouse IgG2a, and PE-mouse
IgG1 were used as isotype controls. All antibodies were purchased from eBio-
sciences. Cells were evaluated using a FACSCalibur flow cytometer (BD Biosci-
ences) and were analyzed with WinMDI 2.9 software (Scripps Research Insti-
tute).
Quantification of TNF-. An enzyme-linked immunosorbent assay (ELISA) to
detect human TNF- was performed using antibodies from BD Pharmingen
following the manufacturer’s instructions. Mouse TNF- was quantified by
ELISA with a TNF- DuoSet ELISA kit (R&D) following the manufacturer’s
instructions. All samples were evaluated in duplicate.
Luciferase assay. L.p-Luc promastigotes were used to infect macrophages for
1 h. Noninternalized parasites were removed by washing, and macrophages were
further incubated for 4, 16, 24, and 36 h. Cells were lysed and analyzed using a
dual-luciferase reporter assay system (Promega) according to the manufacturer’s
instructions.
Statistical analysis. Differences in paired groups were evaluated by Student’s
t test or the Wilcoxon rank test. For group comparisons, the Kruskal-Wallis test
was used with Dunn’s adjustment. Analyses were performed with GraphPad
Prism 5 software (GraphPad Inc., San Diego, CA), and P values of 0.05 were
considered significant.
RESULTS
L. panamensis promastigotes induce TNF- production and
increased expression of TLR1, TLR2, TLR3, and TLR4 by
human macrophages. TNF- production was used as an early
readout of TLR-dependent macrophage activation (reviewed
in reference 59). TNF- secretion following exposure to live
promastigotes peaked at 8 h and decreased by 24 h (Fig. 1A).
The kinetics and levels of production of TNF- by human
macrophages in response to L. panamensis and specific TLR
ligands were comparable (Fig. 1B), consistent with TLR-de-
pendent activation of this host cell by L. panamensis. Stimula-
tion of human macrophages with TLR ligands induced in-
creased expression of the corresponding TLRs (Fig. 2, bottom
panels, and data not shown). Similarly, coculture with live L.
panamensis significantly increased the cell surface expression
of TLR1, TLR2, and TLR4 and the intracellular expression of
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TLR3, but not TLR9, compared to that by unexposed macro-
phages (Fig. 2).
L. panamensis promastigotes and amastigotes activate
TNF- production through TLRs. Based on the results sup-
porting the involvement of TLRs in the L. panamensis-human
macrophage interaction, we investigated the participation of
specific TLRs and adaptor molecules in cell activation. Human
HEK293 cells stably transfected with individual human TLRs
and an NF-B–luciferase reporter construct were used as a
surrogate model of infection and cell activation. However,
HEK293 cells deteriorated during coculture with L. panamen-
sis promastigotes, leading us to examine specific TLR activa-
tion in C57BL/6-derived macrophage cell lines.
TNF- production was induced in a dose-dependent manner
in the WT C57BL/6 macrophage cell line by both promasti-
gotes and amastigotes of L. panamensis over a wide dose range
of parasites (Fig. 3A). In contrast, neither parasite stage
induced TNF- production in the MyD88/TRIF/ double-
knockout macrophage cell line, in which all TLRs are nonfunc-
tional (Fig. 3B), supporting the involvement of TLR-depen-
dent signaling during macrophage activation by L. panamensis.
TNF- secretion levels induced by opsonized and nonop-
sonized parasites were indistinguishable (Fig. 3A and data not
shown), ruling out cell activation attributable to interactions
with serum opsonins in this experimental system.
MD-2, a small protein that together with TLR4 forms the
LPS signaling complex, is an absolute requirement for cells to
respond to LPS (56). Eritoran (previously known as B1287)
binds to the lipid A binding site of MD-2 and is a potent
inhibitor of LPS-mediated activation. Eritoran did not impair
induction of TNF- by L. panamensis, whereas induction by
LPS was blocked (Fig. 3A), thereby establishing that the mac-
FIG. 1. L. panamensis infection induces TNF- production at comparable levels and kinetics to those with specific TLR ligands. (A) Kinetics
of TNF- production in human primary macrophages exposed to different parasite-to-cell ratios, with maximum cytokine secretion at 8 h
postinfection. Data are representative of cytokine production by macrophages of 10 individuals and are expressed as means  standard errors of
the means (SEM). (B) Production of TNF- in human primary macrophages from 10 different donors was measured by ELISA. Cells were
stimulated with zymosan, LPS, or poly(I:C), infected for 8 h with promastigotes at a 5:1 parasite-to-macrophage ratio, or left untreated as a control.
Data are expressed as means  standard deviations (SD). *, P  0.05; **, P  0.01.
FIG. 2. L. panamensis induces increased expression of TLRs 1, 2, 3, and 4 in human macrophages. Human macrophages were cultured without
treatment, infected with L. panamensis promastigotes at a 5:1 parasite-to-macrophage ratio, or stimulated with zymosan (TLR1), Pam2CSK4
(TLR2), poly(I:C) (TLR3), LPS (TLR4), or CpG (TLR9). TLR expression was evaluated by flow cytometry after 8 h of exposure to ligands or
promastigotes. (Top) Mean fluorescence intensities (MFI) of TLR expression from uninfected (empty triangles) and infected (filled circles)
macrophages from 12 different individuals. P values are indicated. (Bottom) Representative histograms of TLR expression of uninfected
macrophages and macrophages exposed to specific TLR ligands or L. panamensis promastigotes. Cells were gated on the CD14 population.
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rophage response to L. panamensis could not be attributable to
LPS contamination.
To dissect the TLR signaling pathway activated by L. pana-
mensis in macrophages, we examined the responses of
MyD88/ and TRIF/ single-knockout macrophages to op-
sonized and nonopsonized parasites. In contrast to the com-
plete abrogation of TNF- secretion in MyD88/TRIF/ dou-
ble-knockout macrophages cocultured with L. panamensis,
specific ablation of either MyD88 or TRIF alone did not sig-
nificantly alter TNF- production (Fig. 4A and B). Similar
results were obtained with opsonized and nonopsonized para-
sites. These results indicate that both MyD88 and TRIF are
required to fully induce TNF- production by L. panamensis in
this experimental system.
Endosomal TLRs participate in macrophage activation by
L. panamensis infection. UNC93b is an endoplasmic reticulum
(ER) membrane protein required for signaling through en-
dolysosomal TLRs (10) by controlling the trafficking of TLRs
3, 7, 8, and 9 from the ER to the endolysosomal compartment.
Hence, UNC93b mutant cells do not respond to the corre-
sponding TLR ligands (28). To investigate the role of the
endolysosomal TLRs during L. panamensis infection, we ex-
amined the activation of macrophages expressing a nonfunc-
tional form of UNC93b (58). Induction of TNF- production
by both L. panamensis promastigotes and amastigotes was sig-
nificantly reduced, though not completely abrogated, com-
pared to that by WT cells (Fig. 5), suggesting that signaling
through the endolysosomal TLRs also contributes to macro-
phage activation during L. panamensis infection.
TLR4 mediates L. panamensis recognition by macrophages.
We next examined the induction of TNF- production in
TLR2/ and TLR4/ macrophage cell lines. As shown in
Fig. 6A, no significant change in TNF- secretion was observed
in TLR2/ macrophages compared to WT cells, suggesting
that TLR2 is not critical for L. panamensis-mediated macro-
FIG. 3. L. panamensis promastigotes and amastigotes induce
TNF- production in a dose-dependent manner and activate macro-
phages through TLR-dependent signaling. (A) TNF- production by
WT macrophages exposed to increasing parasite-to-cell ratios, using
opsonized promastigotes or amastigotes, specific TLR ligands
(hatched bars), or no treatment. (B) MyD88/TRIF/ cells were in-
fected at a 100:1 parasite-to-macrophage ratio. Data are representative
of three independent experiments and are expressed as means SEM.
*, P  0.05.
FIG. 4. MyD88 or TRIF molecules are required for induction of
TNF- production during L. panamensis infection. TNF- production
was measured in MyD88/ (A) and TRIF/ (B) macrophages cocul-
tured with opsonized or nonopsonized L. panamensis promastigotes
and amastigotes at a 100:1 parasite-to-macrophage ratio, stimulated
with specific TLR ligands or Sendai virus (hatched bars), or left un-
treated. Data are from three independent experiments and are ex-
pressed as means  SEM.
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phage activation. In contrast, TNF- production was abro-
gated in TLR4/ macrophages following infection with either
opsonized or nonopsonized promastigotes or amastigotes (Fig.
6B). These results indicate that TLR4, but not TLR2, has an
important role in the induction of proinflammatory cytokine
secretion by macrophages during infection by L. panamensis.
BMMs from MD-2-deficient C57BL/6 mice were used to
confirm the specificity of L. panamensis-mediated macrophage
activation via TLR4 and to rule out unequivocally any activa-
tion attributable to endotoxin contamination. Both promasti-
gotes and amastigotes induced similar and significant levels of
TNF- production in MD-2/ and WT BMMs, confirming
that macrophage activation through TLR4 was induced by L.
panamensis infection (Fig. 6C), not by LPS contamination.
TLR4 is required for induction of leishmanicidal activity of
macrophages. Evaluation of intracellular killing of L. pana-
mensis over the time course of infection from 4 to 48 h showed
that by 16 h postinfection, intracellular parasite survival in WT
macrophages was reduced by up to 70%. In contrast, L. pana-
mensis not only survived but also replicated during the first
16 h in TLR4/ macrophages (Fig. 7A). The parasite burdens
at the initial time point (4 h) of infection were comparable
between WT and TLR4/ cells (165,380 and 143,500 relative
light units [RLU], respectively), confirming similar infection
rates in both cell lines. Confocal microscopy of WT and
TLR4/ cells infected with GFP-transfected parasites corrob-
orated equivalent parasite infectivity and internalization (Fig.
7B). By 24 h postinfection, parasite survival decreased in
TLR4/ macrophages, to levels comparable to those for WT
host cells, supporting the participation of TLR4 during the
very early stages of parasite-macrophage interaction.
Other MyD88-dependent receptors may participate in mac-
rophage activation in response to L. panamensis. To extend the
findings obtained with macrophage cell lines to an infection
approximating natural host cell interaction, we systematically
FIG. 6. L. panamensis induces TNF- production by macro-
phages through TLR4 but not TLR2. TNF- production was mea-
sured in TLR2/ (A) and TLR4/ (B) macrophage cell lines and
in differentiated MD-2/ BMMs (from C57BL/6 mice) (C). BMMs
were left untreated (medium) or cocultured with L. panamensis
promastigotes and amastigotes at a 100:1 parasite-to-macrophage
ratio or were stimulated with specific TLR ligands or LPS alone or
in combination with Eritoran (hatched bars). Figures summarize
three independent experiments and are expressed as means  SEM.
*, P  0.05.
FIG. 5. Endolysosomal TLRs play a role in the induction of TNF-
production during L. panamensis infection. TNF- production was
measured in UNC93b-deficient macrophages cocultured with L. pana-
mensis promastigotes or amastigotes at a 100:1 parasite-to-macro-
phage ratio, stimulated with specific intracellular TLR ligands or LPS
(hatched bars), or left untreated (medium). Data are from three in-
dependent experiments and are expressed as means  SEM. *, P 
0.05.
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evaluated the responses of primary C57BL/6 WT BMMs and
knockout BMMs lacking specific TLRs and adaptor molecules.
As observed in murine cell lines, TNF- production was sig-
nificantly reduced in TLR4/ and MyD88/TRIF/ BMMs
exposed to L. panamensis (Fig. 8A and B). However, in con-
trast to the results for knockout cell lines, in which deficiency
of either MyD88 or TRIF alone did not significantly alter
TNF- production, MyD88/ BMMs cocultured with L. pa-
namensis produced significantly less TNF- upon exposure to
L. panamensis than did WT cells (Fig. 8C and D). Deficiency of
TRIF did not significantly alter TNF production by BMMs. In
addition, a striking and consistently greater production of
TNF- was induced in BMMs by opsonized versus nonop-
sonized parasites. This increased TNF- response coincided
with the higher percentage of infection observed for BMMs
exposed to opsonized parasites (data not shown). The en-
hancement of TNF- secretion by opsonized parasites in this
experimental model is consistent with the participation of re-
ceptors other than TLR4 in L. panamensis-mediated BMM
activation.
DISCUSSION
Macrophages are central to host defense, from pathogen
detection and clearance to the induction of adaptive immune
responses (40). The outcome of Leishmania infection is deter-
mined largely by the ability of macrophages to recognize and
respond to the parasite (4, 6, 8, 9, 37, 41, 52). Although several
macrophage receptors evidently participate in the Leishmania-
host cell interaction (5, 11, 37, 39, 41), their role in the mod-
ulation of host immune responses and clinical outcomes of
infection is not yet clear. This study sought to determine the
participation of TLRs in L. panamensis-mediated modulation
of host cell responses.
Contrary to the negative regulation of host cell functions
reported for L. donovani infection, strong pro- and anti-inflam-
matory cytokine production is a hallmark of infection by par-
asites of the Leishmania (Viannia) subgenus (43). TNF- is
thought to play an important role during L. braziliensis infec-
tion, contributing to disease control in the early stages of in-
fection and to exacerbation of disease at later stages of infec-
tion (2, 16, 50, 53). Mucosal leishmaniasis is characterized by
high levels of TNF- production, and genetic polymorphisms
in the promoter region of TNF genes have been linked to
susceptibility to mucosal disease (4, 13). The early induction of
TNF- production in isolated human macrophages by L.
panamensis promastigotes provided initial evidence of putative
receptor-mediated cell activation. The concurrence of the ki-
netics of TNF- production induced by L. panamensis and by
specific TLR ligands and the upregulation of TLR1, TLR2,
TLR3, and TLR4 expression in human macrophages exposed
to L. panamensis promastigotes (Fig. 2) further supported the
possibility of TLR-mediated activation and TNF- production.
Deletion of both MyD88 and TRIF, essential adaptor mol-
ecules in signal transduction initiated by TLR engagement,
resulted in the abrogation of TNF- secretion by mouse mac-
rophages. This finding demonstrated that host cell activation
by both L. panamensis amastigotes and promastigotes is TLR
dependent. Although differences in macrophage responses to
promastigotes and amastigotes of other Leishmania species are
well documented (29), including decreased superoxide and
increased anti-inflammatory cytokines in response to infection
with amastigotes (15, 46, 47), the induction of TNF- by par-
asites of these life stages was indistinguishable in this experi-
mental infection model. This finding suggests that L. panamen-
sis TLR ligands are expressed similarly by both amastigotes
and promastigotes or, alternatively, that different stage-specific
molecules can redundantly stimulate TLR signaling.
The most compelling evidence to date for the participation
of TLRs in Leishmania infection and pathogenesis is the en-
hanced susceptibility of MyD88-deficient mice to L. major,
accompanied by impaired proinflammatory cytokine synthesis
and diminished Th1 T-cell activation (17, 42). However, this
enhanced susceptibility to L. major has not been attributed to
any specific TLR family member. Using MyD88/ and
TRIF/ macrophage cell lines, we found that the absence of
either of these adaptor molecules did not significantly alter
TNF- production induced by L. panamensis promastigotes or
amastigotes. These findings suggest that signaling in response
to L. panamensis occurs through both pathways and that in the
FIG. 7. TLR4 mediates early macrophage leishmanicidal activity. (A) Parasite infection and survival in WT (C57BL/6) and TLR4/ macro-
phages infected with L.p-Luc promastigotes. The figure shows the RLU for three independent experiments performed in duplicate. **, P  0.01
versus WT cells. (B) Confocal microscopy images of WT and TLR4/ mouse macrophages infected with L.p-GFP promastigotes. Cell membranes
were stained with CellMask Deep Red stain. Images show parasites internalized after 30 min of infection. Images of entire slides (right side) show
a representative overview of WT and TLR4/ macrophage infections.
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absence of either, the other can compensate, sustaining TLR
signaling and host cell activation.
Studies addressing the role of MyD88 in macrophage acti-
vation during infection with the closely related species L. bra-
ziliensis have yielded conflicting results. Recently, Carvalho et
al. showed that TNF- secretion by DCs during L. braziliensis
infection was MyD88 independent (14). In contrast, Vargas-
Inchaustegui and collaborators reported that L. braziliensis-
infected MyD88/ DCs exhibited reduced activation and de-
creased production of IL-12p40, which is fundamental to the
generation of protective immunity (61). Notwithstanding dif-
ferences in experimental models, these results raise the issue of
intra- as well as interspecies variation in TLR-mediated acti-
vation. Despite the similarity of L. braziliensis and L. panamen-
sis as related members of the Viannia subgenus, parasites of
these species may trigger different mechanisms of cell activa-
tion. Therefore, generalization of results obtained with one
species may not be appropriate or accurately portray the in-
teraction with other Leishmania species, even within the same
taxonomic grouping.
The partial abrogation of TNF- production in UNC93b-
deficient mutant macrophages in response to L. panamensis
infection supports the involvement of signaling through en-
dolysosomal TLRs and concurs with evidence of endolyso-
somal TLR participation in the immune response to other
Leishmania species. TLR3 has been implicated in the recogni-
tion of L. donovani by IFN--primed macrophages (21), and
TLR9 has been implicated in DC-mediated NK cell activation
and in T-cell responses following L. infantum and L. major
infection, respectively (33, 55). L. major DNA has been shown
to promote IFN- production by CD4 T cells through TLR9-
dependent activation of DCs (1). The potential therapeutic
applicability of activation through endolysosomal TLRs has
been demonstrated by the enhanced resolution of experimen-
tal L. donovani infection and human cutaneous leishmaniasis
(12, 36), using the TLR7/8 ligand imiquimod. Although our
results support the participation of endolysosomal TLR signal-
ing during L. panamensis infection, the specific TLR(s) in-
volved remains to be identified. Since all of the endolysosomal
TLRs recognize nucleotide ligands, it is reasonable to hypoth-
FIG. 8. Activation of primary bone marrow macrophages by L. panamensis is TLR4 dependent, and signaling is preferentially mediated by
MyD88. TNF- production was measured in differentiated TLR4/ (A), MyD88/ (B), TRIF/ (C), and MyD88/TRIF/ (D) BMMs (from
C57BL/6 mice) left untreated (medium), cocultured with L. panamensis promastigotes at a 100:1 parasite-to-macrophage ratio, or stimulated with
specific TLR ligands or Sendai virus (hatched bars). Figures summarize data from three independent experiments and are expressed as means 
SEM. *, P  0.05.
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esize that Leishmania nucleic acids are involved in the innate
immune response to infection.
TLR2 has been reported to be involved in the host response
to L. major and L. donovani through the recognition of LPG,
which activates human NK cells and murine macrophages
through this receptor (3, 19). Inhibition of TLR2 expression
impaired NO production and TNF- secretion in IFN--
primed mouse macrophages (21). Our results showed that al-
though L. panamensis induced increased TLR2 expression in
human macrophages, the absence of TLR2 in murine macro-
phage lines did not affect TNF- induction by promastigotes or
amastigotes. This finding and the observation that parasites of
the Viannia subgenus express 10-fold less LPG than L. don-
ovani (44) suggest that TLR2 may not be a crucial determinant
of the host cell response to L. panamensis.
The importance of TLR4 signaling in Leishmania infection
is supported by the increased susceptibility of TLR4/
C57BL/6 and BALB/c mice to L. major and L. pifanoi infec-
tions, respectively (30, 31). Furthermore, L. pifanoi P8 PGLC
has been shown to induce TLR4-dependent macrophage cyto-
kine and chemokine production (62). Our data provide evi-
dence that TLR4 is also important during the early L. pana-
mensis-macrophage interaction, since reduced TNF-
production and increased parasite survival occurred in
TLR4/ infected mouse macrophages. The results were fur-
ther supported by ruling out any possibility of attributing ac-
tivation to endotoxin contamination by use of MD-2/ BMMs
(Fig. 6C), thereby providing unequivocal evidence that the
TLR4 response was induced by L. panamensis parasites. The
significant decrease in TNF- production in MyD88/ BMMs
is consistent with the ability of TLR4 to signal preferentially
through MyD88 (25), as previously reported for other Leish-
mania species (18, 19, 42). These findings encourage identifi-
cation of the nature of the ligand(s) involved in the TLR4-
dependent response to L. panamensis.
A noteworthy difference between the activation of immor-
talized macrophage cell lines and BMMs was the enhanced
TNF- secretion induced by opsonized parasites in BMMs.
Under physiological conditions, opsonins (including comple-
ment components and antibodies) interact rapidly with the cell
surfaces of promastigotes after their inoculation into the der-
mis of mammals or with amastigotes when they leave their host
cells (48). Opsonization promotes the uptake of parasites by
phagocytic cells (63), principally mediated by Fc and comple-
ment receptors, and also mediates the release of anti-inflam-
matory cytokines (26, 38, 39). Opsonization could also favor
the synergistic recognition of Leishmania parasites through
various receptors (7), eliciting enhanced or diminished activat-
ing signals and cytokine production (49, 51). Although not
evaluated in this study, differences in expression levels of TLRs
or other receptors that interact with Leishmania, the matura-
tion stage (34), and the functional integrity of permanent cell
lines (45) may account for differences observed in the re-
sponses to parasite opsonization elicited in primary macro-
phages and macrophage cell lines. Interpretation and extrap-
olation of results obtained with cell lines to primary cell
populations or either of these to whole organisms and vice
versa merit consideration of the characteristics and limitations
of each model system. Although the generalization of obser-
vations in these models to natural human infection is uncer-
tain, exploitation of these experimental models allowed the
discrimination of TLRs involved in the L. panamensis-macro-
phage interaction. Findings with human macrophages also sup-
port the involvement of multiple TLRs, including TLR4, in the
host cell interaction with L. panamensis.
In conclusion, our results demonstrate TLR4-mediated mac-
rophage activation and cooperation with other TLRs during
infection by L. panamensis. These findings provide insight into
the mechanism of parasite recognition and give evidence that
early induction of TNF- production mediated by ligation of
TLRs contributes to control of infection. An understanding of
the participation of TLRs in the outcome of Leishmania infec-
tion may allow the exploitation of these receptors or their
ligands in the development of coadjuvant immunotherapy.
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